Thalia Catherine Eley

Thalia Catherine Eley

Auto-generated profile, based on publicly available information

Thalia Catherine Eley

Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
APAntonio F. Pardiñas
Antonio F. Pardiñas
PHPeter Holmans
Peter Holmans
APAndrew J. Pocklington
Andrew J. Pocklington
VEValentina Escott-Price
Valentina Escott-Price
SRStephan Ripke
Stephan Ripke
JWJames T. R. Walters
James T. R. Walters

20 November 2019 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
KPKirstin L. Purves
Kirstin L. Purves
Jonathan ColemanJonathan Coleman
Jonathan Coleman
SMSandra M. Meier
Sandra M. Meier
CRChristopher Rayner
Christopher Rayner
KDKatrina A. S. Davis
Katrina A. S. Davis
TEThalia C. Eley
Thalia C. Eley
Anxiety disorders are common, complex psychiatric disorders with twin heritabilities of 30–60%. We conducted a genome-wide association study of Lifetime Anxiety Disorder (ncase = 25 453, ncontrol = 58 113) and an additional analysis of Current Anxiety Symptoms (ncase = 19 012, ncontrol = 58 113). The liability scale common variant heritability estimate for Lifetime Anxiety Disorder was 26%, and for Current Anxiety Symptoms was 31%. Five novel genome-wide significant loci were identified including an intergenic region on chromosome 9 that has previously been associated with neuroticism, and a locus overlapping the BDNF receptor gene, NTRK2. Anxiety showed significant positive genetic correlations with depression and insomnia as well as coronary artery disease, mirroring findings from epidemiological studies. We conclude that common genetic variation accounts for a substantive proportion of the genetic architecture underlying anxiety.

23 April 2015 in American Journal of Psychiatry
Verified
Journal Article
Closed access
TEThalia C. Eley
Thalia C. Eley
TMTom A. McAdams
Tom A. McAdams
FRFruhling V. Rijsdijk
Fruhling V. Rijsdijk
PLPaul Lichtenstein
Paul Lichtenstein
JNJurgita Narusyte
Jurgita Narusyte
JNJenae M. Neiderhiser
Jenae M. Neiderhiser

23 January 2020 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
Jonathan ColemanJonathan Coleman
Jonathan Coleman
WPWouter J. Peyrot
Wouter J. Peyrot
KPKirstin L. Purves
Kirstin L. Purves
KDKatrina A. S. Davis
Katrina A. S. Davis
CRChristopher Rayner
Christopher Rayner
GBGerome Breen
Gerome Breen

1 August 2014 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
MWMonika A. Waszczuk
Monika A. Waszczuk
HZHelena M. S. Zavos
Helena M. S. Zavos
AGAlice M. Gregory
Alice M. Gregory
TEThalia C. Eley
Thalia C. Eley
Research from JAMA Psychiatry — The Phenotypic and Genetic Structure of Depression and Anxiety Disorder Symptoms in Childhood, Adolescence, and Young Adulthood

25 October 2011 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
TET C Eley
T C Eley
JHJ L Hudson
J L Hudson
CCC Creswell
C Creswell
MTM Tropeano
M Tropeano
KLK J Lester
K J Lester
DCD A Collier
D A Collier
Letter to the Editor. Although pharmacogenetic research thrives, genetic determinants of response to purely psychotherapeutic treatments remain unexplored. In a sample of children undergoing cognitive behaviour therapy (CBT) for an anxiety disorder, we tested whether treatment response is associated with the serotonin transporter gene promoter region (5HTTLPR), previously shown to moderate environmental influences on depression.2 page(s